ALK and lung carcinoma: In fact, compared with other targeted therapies (e.g. ALK-TKI and VEGFR), EFGR-TKI treatments result in more severe skin ADRs, which is especially true for lung cancer treatment, in which EGFR-TKIs have been commonly used.